An international research group led by Arizona State University professor Qiang "Shawn" Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus, and other pathogens.The therapeutics, known as monoclonal antibodies (MAbs) and their derivatives, were shown to neutralize and protect mice against a lethal dose challenge of West Nile virus - even as late as 4 days after the initial infection.
from Health News from Medical News Today http://ift.tt/1mnXJsr
from Health News from Medical News Today http://ift.tt/1mnXJsr
Aucun commentaire:
Enregistrer un commentaire